Control of Motoneuron Survival by Angiogenin

Article Information

DOI

PubMed

Published By

History

¹Department of Physiology and Medical Physics and Royal College of Surgeons in Ireland (RCSI) Neuroscience Research Centre, RCSI, Dublin 2, Ireland,
²National Centre for Medical Genetics, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland, and
³Department of Neurology, Beaumont Hospital, Dublin 11, Ireland

Correspondence should be addressed to Prof. Jochen H. M. Prehn, Department of Physiology and Medical Physics and RCSI Neuroscience Research Centre, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland. prehn{at}rcsi.ie

D. Kieran's present address: Laboratory of Neurodegenerative Studies, Brain Mind Institute, Ecole Polytechnique Federal de Lausanne, AI 1106, Lausanne CH-1015, Switzerland.

D. Kieran's present address: Laboratory of Neurodegenerative Studies, Brain Mind Institute, Ecole Polytechnique Federal de Lausanne, AI 1106, Lausanne CH-1015, Switzerland.

This work was supported by grants from Science Foundation Ireland to J.H.M.P. (03/RP1/B344), Enterprise Ireland to D.K., O.H., and J.H.M.P. (PC2005/133; PC2007/045), and a Health Research Board Fellowship and studentship to M.J.G. and D.C., respectively. D.K., M.J.G., O.H., and J.H.M.P. are inventors on patents relating to the use of angiogenin for the treatment of CNS diseases. We are grateful to Dr. Patrick Dicker (Department of Epidemiology and Public Health, Royal College of Surgeons in Ireland) for his help with statistical analysis. NSC34 cells (Dr. N. Cashman, University of Toronto, Toronto, Ontario, Canada) were obtained from Prof. P. J. Shaw, University of Sheffield, United Kingdom.
Correspondence should be addressed to Prof. Jochen H. M. Prehn, Department of Physiology and Medical Physics and RCSI Neuroscience Research Centre, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland. prehn{at}rcsi.ie

Select a custom date range for the past year